![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » U.S. FEDERAL TRADE COMMISSION EXTENDS ANTITRUST REVIEW OF BARR'S PROPOSED PLIVA BUY
U.S. FEDERAL TRADE COMMISSION EXTENDS ANTITRUST REVIEW OF BARR'S PROPOSED PLIVA BUY
August 16, 2006
The Federal Trade Commission has extended its antitrust review of Barr Pharmaceuticals Inc.'s proposed tender offer to acquire Pliva d.d., a Croatian generic-drug maker, Barr said. Find Law (http://news.findlaw.com/ap/o/51/08-15-2006/ad65000ef98faba1.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct